Article Versions Notes

Weninger A, Sagasser J, Obermoser V, Egger J, Wisboeck S, Qiu Q, Ladstaetter M, Cucchiaro A, Wurst K, Baecker D, et al. Development of Zeise’s Salt Derivatives Bearing Substituted Acetylsalicylic Acid Substructures as Cytotoxic COX Inhibitors. Pharmaceutics. 2023; 15(6):1573. https://doi.org/10.3390/pharmaceutics15061573

Weninger, Alexander, Jessica Sagasser, Victoria Obermoser, Josef Egger, Susanna Wisboeck, Qianqian Qiu, Miriam Ladstaetter, Andrea Cucchiaro, Klaus Wurst, Daniel Baecker, and et al. 2023. "Development of Zeise’s Salt Derivatives Bearing Substituted Acetylsalicylic Acid Substructures as Cytotoxic COX Inhibitors" Pharmaceutics 15, no. 6: 1573. https://doi.org/10.3390/pharmaceutics15061573

Weninger, A., Sagasser, J., Obermoser, V., Egger, J., Wisboeck, S., Qiu, Q., Ladstaetter, M., Cucchiaro, A., Wurst, K., Baecker, D., & Gust, R. (2023). Development of Zeise’s Salt Derivatives Bearing Substituted Acetylsalicylic Acid Substructures as Cytotoxic COX Inhibitors. Pharmaceutics, 15(6), 1573. https://doi.org/10.3390/pharmaceutics15061573